Filing Details

Accession Number:
0001104659-21-149797
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-15 08:30:01
Reporting Period:
2021-12-10
Accepted Time:
2021-12-15 08:30:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124524 Cryoport Inc. CYRX Pharmaceutical Preparations (2834) 880313393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283212 Jerrell Shelton C/O Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood TN 37027
President, Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-10 26,418 $2.40 590,510 No 4 M Direct
Common Stock Acquisiton 2021-12-10 38,545 $3.24 629,055 No 4 M Direct
Common Stock Disposition 2021-12-10 16,427 $64.94 612,628 No 4 S Direct
Common Stock Disposition 2021-12-10 8,710 $65.57 603,918 No 4 S Direct
Common Stock Disposition 2021-12-10 1,281 $66.89 602,637 No 4 S Direct
Common Stock Disposition 2021-12-10 29,144 $64.89 573,493 No 4 S Direct
Common Stock Disposition 2021-12-10 8,092 $65.54 565,401 No 4 S Direct
Common Stock Disposition 2021-12-10 1,309 $66.87 564,092 No 4 S Direct
Common Stock Acquisiton 2021-12-13 287 $3.24 564,379 No 4 M Direct
Common Stock Disposition 2021-12-13 200 $64.87 564,179 No 4 S Direct
Common Stock Disposition 2021-12-13 87 $65.84 564,092 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase common stock Disposition 2021-12-10 26,418 $0.00 26,418 $2.40
Common Stock Option to purchase common stock Disposition 2021-12-10 38,545 $0.00 38,545 $3.24
Common Stock Option to purchase common stock Disposition 2021-12-13 287 $0.00 287 $3.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-11-05 No 4 M Direct
286,664 2023-06-28 No 4 M Direct
286,377 2023-06-28 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.34, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.36 to $66.23, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.57, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.35, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.36 to $66.35, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.6950, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.18, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. 1/12 of the options vested on the 22nd of each month for twelve months beginning on 11/22/2012 and ending on 10/22/2013.
  10. 1/6 of the options vested on the 5th of each month for six months beginning on 12/5/2012 and ending on 5/5/2013.
  11. 1/24 of the options vested immediately and 1/46 of the remaining options vested on the 5th of each month for forty six months beginning on 7/5/2013 and ending on 5/5/2017.